Price (delayed)
$17.4
Market cap
$1.09B
P/E Ratio
17.23
Dividend/share
N/A
EPS
$1.01
Enterprise value
$1.28B
Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.
There are no recent dividends present for INVA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.